I hear ya firestorm... it was a very broadbrush comparison... I'm sure Ext will generating huge cashflows eventually.
I'm hoping BTA/DS get a similar royalty cut to Gilead for Tamiflu... which would mean BTA's cut would be around what they get now for Relenza...
Sorry for hijacking this thread... I know its meant to be a discussion on TA...
